|
Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
5
|
Resverlogix Corp.
|
Dec 21, 2021 08:42PM
|
|
Re: Resverlogix: The Future of Drug Development, CEO Clip Video
|
3
|
Resverlogix Corp.
|
Dec 16, 2021 06:25PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
7
|
Resverlogix Corp.
|
Nov 29, 2021 11:31PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
1
|
Resverlogix Corp.
|
Nov 29, 2021 07:52PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
6
|
Resverlogix Corp.
|
Nov 29, 2021 07:45PM
|
|
Re: Time keeps ticking
|
3
|
Resverlogix Corp.
|
Nov 19, 2021 01:24PM
|
|
Re: Here is the example of the danger of the COVID trial to RVX...
|
5
|
Resverlogix Corp.
|
Nov 11, 2021 01:22PM
|
|
Re: "Actively Recruiting" ?
|
13
|
Resverlogix Corp.
|
Nov 09, 2021 03:41PM
|
|
Re: A look at the competition.
|
3
|
Resverlogix Corp.
|
May 17, 2021 09:28PM
|
|
Re: Ethics
|
3
|
Resverlogix Corp.
|
May 13, 2021 09:44PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 02:19PM
|
|
COVID-19 treatment with RVX
|
8
|
Resverlogix Corp.
|
Apr 12, 2021 02:27PM
|
|
Re: Vaccines are here. That’s no reason to call off the hunt for effective COVID-19 treatments. Article from Market Watch...good read.
|
7
|
Resverlogix Corp.
|
Mar 19, 2021 08:55PM
|
|
Re: Vaccines are here. That’s no reason to call off the hunt for effective COVID-19 treatments. Article from Market Watch...good read.
|
8
|
Resverlogix Corp.
|
Mar 19, 2021 08:22PM
|
|
the silence of the mgmt indicates...
|
10
|
Resverlogix Corp.
|
Mar 19, 2021 05:49PM
|
|
Re: RVX's place in therapy - future prediction
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 09:10AM
|
|
Re: RVX's place in therapy - future prediction
|
5
|
Resverlogix Corp.
|
Mar 13, 2021 03:50PM
|
|
RVX's place in therapy - future prediction
|
7
|
Resverlogix Corp.
|
Mar 13, 2021 10:28AM
|
